Employees: 01 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2007-03-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NANTERRE (92000), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA BOULE : revenue, balance sheet and financial ratios
PHARMACIE DE LA BOULE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NANTERRE (92000),
this company of category PME
shows in 2016 a revenue of 928 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA BOULE (SIREN 494667579)
Indicator
2024
2021
2016
Revenue
N/C
N/C
927 607 €
Net income
38 561 €
156 740 €
21 870 €
EBITDA
N/C
N/C
27 317 €
Net margin
N/C
N/C
2.4%
Revenue and income statement
In 2024, PHARMACIE DE LA BOULE generates positive net income of 39 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 22 k€ -> 39 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
38 561 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
5.092%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
75.461%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA BOULE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2021
2024
Debt ratio
-15.168
89.898
5.092
Financial autonomy
-19.414
32.916
75.461
Repayment capacity
-5.859
None
None
Cash flow / Revenue
-0.183%
None%
None%
Sector positioning
Debt ratio
5.092024
2016
2021
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE DE LA BOULE (5.09) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
75.46%2024
2016
2021
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+55 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA BOULE (75.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
-5.86 years2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Excellent
In 2016, the repayment capacity of PHARMACIE DE LA BOULE (-5.86) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 465.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
465.601
Liquidity indicators evolution PHARMACIE DE LA BOULE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2021
2024
Liquidity ratio
50.656
244.228
465.601
Interest coverage
1.289
None
None
Sector positioning
Liquidity ratio
465.62024
2016
2021
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent+53 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA BOULE (465.60) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.29x2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.32x
Average
In 2016, the interest coverage of PHARMACIE DE LA BOULE (1.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA BOULE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2021
2024
Operating WCR
80 795 €
0 €
0 €
Inventory turnover (days)
37
0
0
Customer payment term (days)
0
0
0
Supplier payment term (days)
136
0
0
Positioning of PHARMACIE DE LA BOULE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA BOULE is estimated at
538 340 €
(range 374 891€ - 805 387€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
374k€538k€805k€
538 340 €Range: 374 891€ - 805 387€
NAF 5 année 2024
Valuation method used
Net Income Multiple
38 561 €
×
14.0x
=538 340 €
Range: 374 892€ - 805 388€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA BOULE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA BOULE
What is the revenue of PHARMACIE DE LA BOULE ?
The revenue of PHARMACIE DE LA BOULE in 2016 is 928 k€.
Is PHARMACIE DE LA BOULE profitable?
Yes, PHARMACIE DE LA BOULE generated a net profit of 39 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA BOULE ?
The headquarters of PHARMACIE DE LA BOULE is located in NANTERRE (92000), in the department Hauts-de-Seine.
Where to find the tax return of PHARMACIE DE LA BOULE ?
The tax return of PHARMACIE DE LA BOULE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA BOULE operate?
PHARMACIE DE LA BOULE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart